Lund OsteoArthritis Division - Molecular marker research group
21 – 30 of 187
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reflections on 30 years of publishing osteoarthritis research : Where we've been and where we're going
- Contribution to journal › Debate/Note/Editorial
-
Mark
The coexistence of diabetes, hypertension and obesity is associated with worse pain outcomes following exercise for osteoarthritis : A cohort study on 80,893 patients
- Contribution to journal › Article
-
Mark
Digital self-management, analgesic use and patient-reported outcomes in knee or hip osteoarthritis
- Contribution to journal › Article
-
Mark
“You don't put it down to arthritis” : A qualitative study of the first symptoms recalled by individuals with knee osteoarthritis
- Contribution to journal › Article
-
Mark
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis : 2023 update
(2024) In Annals of the Rheumatic Diseases
- Contribution to journal › Article
-
Mark
Biomarkers have to make sense
- Contribution to journal › Debate/Note/Editorial
-
Mark
Sex and age differences in the patient-reported outcome measures and adherence to an osteoarthritis digital self-management intervention
- Contribution to journal › Article
-
Mark
Development of methodology to support molecular endotype discovery from synovial fluid of individuals with knee osteoarthritis : The STEpUP OA consortium
- Contribution to journal › Article
-
Mark
Work-restricting musculoskeletal pain after bariatric surgery or usual obesity care in the Swedish Obese Subjects study
- Contribution to journal › Article
-
Mark
Serum ARGS-aggrecan in a phase 2 clinical trial targeting osteoarthritis
- Contribution to journal › Article
